PDF Mãn dục nam, vai trò của Testosterone trong bệnh tim mạch chuyển hóa, bí quyết để duy trì sự ham muố

Mãn dục nam, vai trò của Testosterone trong bệnh tim mạch chuyển hóa, bí quyết để duy trì sự ham muốn dài lâu

 

Mục lục:

LỜIGIỚITHIỆU............................................................................................................ 3

GIỚI THIỆU VÀI NÉTVỂTÁCGIẢ................................................................................ 6

LỜI NÓI ĐẤU............................................................................................................... 7

LỜI CẢM ƠN............................................................................................................. 10

Chương I. GIẢI PHẪU VÀ SINH LÝ CỦA TINH HOÀN

I. GIẢI PHẪU TINH HOÀN VÀ cơ QUAN SINH DỤCTRONG CỦA NAM GIỚI..... 17

II. Sự ĐIỀU HÒA TRỤC DƯỚI ĐỔI-TUYÊN YÊN-TINH HOÀN.......................... 20

III. SINH TỔNG HỢP TESTOSTERONE.......................................................... 22

IV. CHUYỂN HÓA TESTOSTERONE.............................................................. 24

V. CƠCHÊHOẠTĐỘNGCỦATESTOSTERONE................................................. 24

VI. CÁC TÁC DỤNG SINH LÝ CỦA TESTOSTERONE....................................... 26

1. Thời kỳ bào thai............................................................................. 27

2. Mới sinh........................................................................................ 27

3. Trước thời kỳ dậy thì..................................................................... 27

4. Thời kỳ dậy thì............................................................................. 28

5. Người trưởng thành....................................................................... 29

VII. CÁC ẢNH HƯỞNG SINH HỌC KHÁC CỦATESTOSTER.............................. 30

1. Ảnh hưởng của testosterone đến bộ não........................................ 30

2. Hệ xương...................................................................................... 30

3. Hệ hô hấp..................................................................................... 31

4. Hệ tạo máu................................................................................... 31

5. ức chế sản sinh tế bào mỡ............................................................. 31

6. Ngăn ngừa ung thư và các nguy cơ đối với sức khỏe....................... 32



VIII. TESTOSTERONE VÀ HAM MUỐN TÌNH DỤC......................................... 32

1. Các nghiên cứu ở động vật có vú.................................................... 33

2. Ham muốn tình dục ở nam giới...................................................... 34

3. Ham muốn tình dục ở nữ giới......................................................... 36

IX. TESTOSTERONE VÀ TÂM LÝ, TÌNH CẢM............................................. 37

1. Hành vi và nhân cách..................................................................... 37

2. Sự hung hãn và tội ác.................................................................... 37

3. Mối quan hệ lãng mạn và tình cảm cha con..................................... 38

X. TESTOSTERONE VÀ SựTHÀNH ĐẠT....................................................... 39

XI. CÁC ỨNG DỤNG TRONG Y HỌC............................................................ 41

XII. SỬ DỤNG ĐỐI VỚI VẬN ĐỘNG VIÊN................................................... 42

Chương II. VAI TRÒ CỦA TESTOSTERONE TRONG BỆNH TIM MẠCH
CHUYỂN HÓA

I. TESTOSTERONE VÀ BÉO PHÌ.................................................................. 44

II. TESTOSTERONEVÀĐÁITHĂOĐƯỜNG, HỘI CHỨNG CHUYỂN HÓA............ 47

III. TESTOSTERONE VÀ BỆNH TIM MẠCH, xơ VỮA ĐỘNG MẠCH................... 52

IV. TESTOSTERONE VÀ SUYTIM................................................................. 56

Chương III. ẢNH HƯỞNG CỦA GIẢM TESTOSTERONE TRONG

SUY SINH DỤC NAM KHỞI PHÁT MUỘN

I. TESTOSTERONE VÀ TUYẾN TIẾN LIỆT.................................................... 57

II. TESTOSTERONE VÀ RỐI LOẠN CƯƠNG DƯƠNG...................................... 61

III. TESTOSTERONE VÀ TÂM TRẠNG, NHẬN THỨC...................................... 63

IV. NHỮNG ẢNH HƯỞNGTRÊN XƯƠNG VÀ LOÃNG XƯƠNG......................... 65

Chương IV. NGUYÊN NHÂN GÂY SUY SINH DỤC NAM KHỞI PHÁT MUỘN

I. TUỔI TÁC.............................................................................................. 69

II. NGUYÊN NHÂN DO TINH HOÀN............................................................. 72

III. MẤT CÂN BẰNG NỘI TIẾT..................................................................... 73



IV. DINH DƯỠNG....................................................................................... 73

V. GLUCOCORTICOIDE.............................................................................. 74

VI. BỆNH ở TUYẾN YÊN, VÙNG DƯỚI ĐỔI.................................................. 74

VII. SUY SINH DỤC DO BỆNH TOÀN THÂN VĂ NHIỄM ĐỘC NGOẠI SINH..... 74

1. Các bệnh toàn thân....................................................................... 75

2. Thuốc, tia xạ và ô nhiễm môi trường.............................................. 86

Chương V. BIỂU HIỆN LÂM SÀNG CỦA SUY SINH DỤC NAM
KHỞI PHÁT MUỘN

Chương VI. CHẨN ĐOÁN suY SINH DỤC NAM KHỞI PHÁT MUỘN

I. LÂM SÀNG............................................................................................ 110

1. Hỏi bệnh sử................................................................................... 110

2. Khai thác tiền sử............................................................................ 111

3. Khám thực thể............................................................................... 111

II. CÁC THĂM DÒ VỂ HORMON................................................................. 113

1. Testosterone................................................................................. 113

2. Gonadotropin................................................................................ 116

3. Các xét nghiệm động học............................................................... 117

4. Đo nồng độ prolactin..................................................................... 118

III. CÁC THĂM DÒ KHÁC........................................................................... 118

1. Phân tích tinh dịch......................................................................... 118

2. Đo mật độ xương........................................................................... 119

3. Thăm dò hình ảnh tuyến yên.......................................................... 119

4. Sinh thiết tinh hoàn và thăm dò bìu................................................ 119

5. Siêu âm tinh hoàn......................................................................... 119

IV. CHẨN ĐOÁN SUY SINH DỤC NAM KHỞI PHÁT MUỘN............................ 121

Chương VII. LIÊU PHÁP TESTOSTERONE THAY THÊ

I. CÁC DẠNG BÀO CHÊ'TESTOSTERONE..................................................... 125

1. Các thuốc dạng uống.................................................................... 125



2. Dạng tiêm trong cơ...................................................................... 126

3. Liệu pháp testosterone qua da..................................................... 128

4. Ngậm dưới lưỡi và niêm mạc má.................................................. 131

5. cấỵ dưới da................................................................................. 132

II. CÁC LỢI ÍCH CỦA LIỆU PHÁPTESTOSTERONETHAYTHẾ......................... 132

1. Cải thiện tâm trạng, hành vi và chất lượng cuộc sống....................................... 133

2. Cải thiện chức năng nhận thức....................................................... 138

3. Cải thiện ham muốn, chức năng và khả năng tình dục..................... 141

4. Phát triển và duy trì các đặc tính nam giới...................................... 145

5. Có thể bình thường hóa hormon tăng trưởng ở nam giới lớn tuổi..... 146

6. Cải thiện cấu trúc cơ thể, khối lượng và sức mạnh cơ bắp................ 146

7. Tối Ưu hóa mật độ xương và phòng chống loãng xương.................. 147

8. Cải thiện tình trạng thiếu máu........................................................ 151

9. Cải thiện hội chứng chuyển hóa, đái tháo đường type 2, bệnh tim mạch....l 52

III. CÁC NGUY Cơ CỦA LIỆU PHÁP TESTOSTERONE THAY TH Ế.................. 155

1. Phì đại tuyến tiền liệt lành tính....................................................... 156

2. Ung thư tuyến tiền liệt................................................................... 156

3. Các vấn đề về gan......................................................................... 161

4. Nguy cơ đa hồng cầu..................................................................... 162

5. Những ảnh hưởng vể sinh sản........................................................ 163

6. Chứng vú to ở nam giới................................................................. 164

7. Hội chứng ngừng thở khi ngủ do tắc nghẽn.................................... 164

8. Tăng huyết áp và bệnh tim mạch................................................... 166

9. Thay đổi hành vi............................................................................ 157

10. Các tác dụng không mong muốn khác của liệu pháp testosterone

thay thế.............................................................................................. 167



IV. THEO DÕI NGƯỜI BỆNH sử DỤNG LIỆU PHÁP TESTOSTERONE THAY


THẾ.................................................................................................... 168

V. CÁC CHÓNG CHỈ ĐỊNH CỦA LIỆU PHÁPTESTOSTERONE THAYTHẾ........ 169

VI. KẾT LUẬN.......................................................................................... 170

Chương VIII. BÍ QUYẾT ĐỂ DUY TRÌ sự HAM MUỐN DÀI LÂU

I. ĂN UỐNG HỢP LÝ................................................................................. 173

1. Thịt đỏ nạc.................................................................................... 174

2. Gà tây........................................................................................... 174

3. Trứng............................................................................................ 175

4. Hàu .............................................................................................. 175

5. Các loại thủy sản có vỏ cứng.......................................................... 176

7. Sữa và sữa chua............................................................................ 176

8. Sô cô la......................................................................................... 176

9. Chuối............................................................................................ 177

10. Quả lê tàu................................................................................... 177

11. Quả bơ........................................................................................ 178

12. Măng tây..................................................................................... 178

13. Các loại hạt.................................................................................. 179

14. Các loại ngũ cốc chứa nhiều chất xơ.............................................. 179

II. ĐI Bộ ĐỂU ĐẶN................................................................................... 179

III. GIẢM CÂN.......................................................................................... 181

IV. HẠN CHÊ'RƯỢU BIA............................................................................ 183

V. CAI THUỐC LÁ.................................................................................... 184

VI. KIỂM SOÁT CẢM XÚC TIÊU cực........................................................... 184

VII. SỬ DỤNG MỘT SỐ BÀI THUỐC ĐÔNG Y............................................. 186

VIII. TẬP LUYỆN KHÍ CÔNG...................................................................... 188



1. Thở bụng tối đa.......................................................................... 191

2. Thở bụng tự nhiên...................................................................... 193

3. Thở bụng nghịch......................................................................... 195

IX. TẬP YOGA.......................................................................................... 196

Bảy trung tâm năng lượng (7 Luân Xa).............................................. 199

Năm tư thế Yoga theo "Suối nguồn tươi trẻ"...................................... 201

X. LUYỆN GIỌNG NÓI............................................................................. 211

XI. TẬP THIỂN......................................................................................... 215

XII. SỬ DỤNG MỘT SỐ THẢO DƯỢC......................................................... 220

THAY CHO LỜI KÉT............................................................................... 225

TÀI LIỆU THAM KHẢO............................................................................... 227

 

tài liệu tham khảo:

TÀI LIỆU THAM KHẢO
Tiếng Việt
1. Trần Quán Anh, Nguyễn Phương Hồng. Rối loạn cương dương. Bệnh học giới tính nam. NXB Yhọc 2009; 400-479.
2. Trần Quán Anh. Mãn dục nam giới. Bệnh học giới tính nam. NXB Yhọc 2009; 323-252.
3. Trần Quán Anh. Rối loạn xuất tinh. Bệnh học giới tính nam. NXB Yhọc 2009; 480-427.
4. Trần Quán Anh.Tinh trùng. Bệnh học giới tính nam. NXB Yhọc 2009; 72-122.
5. Lyengar BKS. Kỹ thuật và thực hành Yoga toàn tập. NXB Phụ nữ, 2009.
6. Võ Văn Bản. Thực hành điều trị tâm lý. NXB Yhọc, 2008.
7. Trần Thị Trung Chiến. Giải phẫu và sinh lý mó học hệ sinh sản nam. Bệnh học giới tính nam. NXB Yhọc, 2009; 123-187.
8. Lê Hùng. Mãn dục nam dưới góc nhìn của y học cổ truyền. Tạp chí Y học Việt Nam, 2013; 403:143-147.
9. Phạm Gia Khải. Bệnh tim mạch và tình dục. Tạp chí Y học Việt Nam, 2013;403:33-37.
10. Bùi Ngọc An Pha. Vai trò của Eurycome Longifolia trong việc duy trì sự ổn định testosterone máu, một phương pháp hỗ trợ cải thiện hội chứng chuyển hóa.Tợp chí Y học Việt Nam, 2013;403:221-227.
11. Nguyễn Hải Thủy. Testosterone, yếu tố nguy cơ tim mạch ở bệnh nhân đái tháo đường. Tạp chí Yhọc Việt Nam, 2013;403:73-83.
12. Nguyễn Bửu Triều. Nội tiết tố liên quan đến vấn để sinh sản. Bệnh học giới tính nam. NXB Yhọc 2009; 7-71.
13. Vidal Việt Nam. CMP Medica, 2010.


Vai trò của Testosterone trong bệnh tim mạch chuyển hóa
Tiếng nước ngoài
14. Ajayi AA, Halushka PV. Castration reduces platelet thromboxane A2 receptor density and aggregability. QJM 2005; 98 (5): 349-56.
15. Ajayi AA, Mathur R, Halushka PV. Testosterone increases human platelet thromboxane A2 receptor density and aggregation responses. Circulation 1995; 91 (11): 2742-7.
16. Allan CA, McLachlan Rl. Age-related changes in testosterone and the role of replacement therapy in older men. Clin Endocrinol 2004; 60:653-670.
17. American Heart Association. Heart disease and stroke statistics. Dallas: American Heart Association; 2002.
18. Amiaz RA, Seidman SN, Stuart NB. Testosterone and depression in men. CurrOpin Endocrinol Diabetes Obes 2008; 15(3):278-283.
19. Amory JK, Watts NB, Easley KA, et al. Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone. J Clin Endocrinol Metab 2004;89:503-510.
20. Andersen ML, Tufik s. The effects of testosterone on sleep and sleep-disordered breathing in men: its bidirectional interaction with erectile function. Sleep Med Rev 2008; 12 (5): 365-79.
21. Araujo A, Kupelian V, Page ST, Handelsman DJ, BremnerWJ, McKinlay JB. Sex steroids and all-cause mortality and cause-specific mortality in men. Arch Intern Med 2007; 167:1252-1260.
22. Araujo AB, O'Donnell A, Brambilla DJ, et al. Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study. J Clin Endocrinol Metab 2004; 89:5920-5926.
23. Archer JS, Love-Geffen TE, Herbst-Damm KL, Swinney DA, Chang JR. Effect of estradiol versus estradiol and testosterone on brain-activation patterns in postmenopausal women. Menopause 2006; 13:528-37.

24. Armanini D, Mattarello MJ, Fiore c, Bonanni G, Scaroni c, Sartorato p, Palermo M. Licorice reduces serum testosterone in healthy women. Steroids 2004; 69 (11-12): 763-6.
25. Aversa A, Isidori AM, Greco EA, Giannetta E, Gianfrilli D, Spera E, et al. Hormonal supplementation and erectile dysfunction. Eur Urol 2004;45:535-538.
26. Aversa A, Isidori AM, Spera G, et al. Androgens improve cavernous vasodilation and response to sildenafil in patients with erectile dysfunction. Clin Endocrinol (Oxf) 2003; 58:632-8.
27. Bagatell CJ, Heiman JR, Rivier JE, Bremner WJ. Effects of endogenous testosterone and estradiol on sexual behavior in normal young men. J Clin Endocrinol Metab 1994; 78:711-716.
28. Barrett-Connor E, Goodman-Gruen D, Patay B. Endogenous sex hormones and cognitive function in older men. J Clin Endocrinol Metab 1999; 84:3681 -3685.
29. Bassil N, AlkaadeS,MorleyJE.Thebenefitsand risks of testosterone replacement therapy: a review. Ther Clin Risk Manag 2009; 5 (3): 427-48.
30. Basu R, Dalia MC, Campioni M, et al. Effect of 2 years of testosterone replacement on insulin secretion, insulin action, glucose effectiveness, hepatic insulin clearance, and postprandial glucose turnover in elderly men. Diabetes Care 2007; 30:1972-1978.
31. Baum N, Candace A, Crespi CA. Testosterone replacement in elderly men. Geriatrics 2007; 62:15-18.
32. Beauchet 0. Testosterone and cognitive function: current clinical evidence of a relationship. Eur J Endocrinol 2006; 155:773-781.
33. Behre HH, Kliesch s, Leifke E, LinkTM, Nieschlag E. Long term effect of testosterone therapy on bone mineral density in hypogonadal men. J Clin Endocrinol Metab 1997; 82:2386-2390.

230 MÃN DỤC NAM
Vai trò của Testosterone trong bệnh tim mạch chuyển hóa
34. Behre HM, Kliesch s, Leifke E, LinkTM, Nieschlag E. Long-term effect of testosterone therapy on bone mineral density in hypogonadal men. J Clin Endocrinol Metab 1997; 82:2386.
35. Bell EC, Willson MC, Wilman AH, Dave s, Silverstone PH. Males and females differ in brain activation during cognitive tasks. Neuroimage 2006; 30:529-38.
36. Berg SJ, Wynne-Edwards KE. Changes in testosterone, cortisol, and estradiol levels in men becoming fathers. Mayo Clinic Proceedings 2001; 76(1): 582-592.
37. Bhasin s, Cunningham GR, Hayes FJ, et al. Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2006; 91:1995-2010.
38. Bhasin s, Cunningham GR, Hayes FJ, et al. Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2006; 91:1995-2010.
39. Bhasin s, Singh AB, Mac RP,Carter B, Lee Ml, Cunningham GR. Managing the risks of prostate disease during testosterone replacement therapy in older men: recommendations for a standardized monitoring plan. JAndro/2003; 24:299-311.
40. Bhasin s. The dose-dependent effects of testosterone on sexual function and on muscle mass and function. Mayo Clinic Proc 2000; 75(suppl):S70-S75.
41. Black AM, Day AG, Morales A. The reliability of clinical and biochemical assessment in symptomatic late-onset hypogonadism: Can a case be made for a 3-month therapeutic trial? BJU Int 2004; 94:1066-1070.
42. Bolour s, Braunstein G. Testosterone therapy in women: a review. Int J Impot Res 2005; 17 (5): 399-408.
43. Booth A, Johnson DR, Granger DA.Testosterone and men's depression: the role of social behavior. J Health Soc Behav 1999; 40:130-140.

44. Booth A, Johnson DR, Granger DA. Testosterone and men's health. J Behov Med 1999; 22 (1): 1-19.
45. Bowen RL, Isley JP, Atkinson RL. An association of elevated serum gonadotropin concentrations and Alzheimer disease? J Neuroendocrinal 2000; 12(4)351-354.
46. Bratoeff E, Cabeza M, Ramirez E, Heuze Y, Flores E. Recent advances in the chemistry and pharmacological activity of new steroidal antiandrogens and alpha-reductase inhibitors. CurrMed Chem 20ỒS; 12 (8): 927-43.
47. Bremner WJ, Vitiello MV, Prinz PN. Loss of circadian rhythmicity in blood testosterone levels with aging in normal men. J Clin Endocrinol Metứò 1983; 56:1278-1281.
48. Bunch TJ, Abraham D, Wang 8, Meikle AW. Pituitary radiographic abnormalities and clinical correlates of hypogonadism in elderly males presenting with erectile dysfunction. Aging Mole 2002; 5:38-46.
49. Buvat J, Lemaire A. Endocrine screening in 1,022 men with erectile dysfunction: clinical significance and cost-effective strategy. J Urol 1997; 158:1764-1767.
50. Calistro Alvarado L. Population differences in the testosterone levels of young men are associated with prostate cancer disparities in older men. Am J Hum Biol 2010; 22 (4): 449-55.
51. Calof OM, Singh AB, Lee ML, et al. Adverse events associated with testosterone replacement in middle-aged and older men: a meta¬analysis of randomized, placebo-controlled trials. J Gerontol A Biol Sci Med Sei 2005; 60:1451-1457.
52. Cavallini G, Caracciolo s, Vitali G, Modenini F, Biagiotti G. Carnitine versus androgen administration in the treatment of sexual dysfunction, depressed mood, and fatigue associated with male aging. Urology 2004; 63:641-646.
53. Chavarro JE, Toth TL, Wright DL, Meeker JD, Hauser R. Body mass index in relation to semen quality, sperm DNA integrity, and serum


Vai trò của Testosterone trong bệnh tim mạch chuyển hóa
reproductive hormone levels among men attending an infertility clinic. Fertil Steril 2010; 93:2222-2231.
54. Cherrier MM, Matsumoto AM, Amory JK, Asthana s, Bremner w, Peskind ER, et al.Testosterone improves spatial memory in men with Alzheimer disease and mild cognitive impairment. Neurology 2005; 64:2063-2068.
55. Cohen PG. The hypogonadal-obesity cycle. Med Hypotheses 1999; 52:49-51.
56. Compston JE. Sex steroids and bone. Physiol Rev 2001; 81 (1 ):419-447.
57. Corrales JJ, Burgo RM, Garca-Berrocal B, et al. Partial androgen deficiency in aging type 2 diabetic men and its relationship to glycemic control. Metabolism 2004; 53:666-672.
58. Corrales JJ, Burgo RM, Garca-Berrocal B, et al. Partial androgen deficiency in aging type 2 diabetic men and its relationship to glycemic control. Metabolism 2004; 53:666-72.
59. Cosgrove KP, Mazure CM, Staley JK. Evolving knowledge of sex differences in brain structure, function, and chemistry. Biol Psychiatry 2007; 62 (8): 847-55.
60. Cox RM, John-Alder HB. Testosterone has opposite effects on male growth in lizards (Sceloporus spp.) with opposite patterns of sexual size dimorphism. J. Exp. Biol 2005; 208 (24): 4679-87.
61. Cunningham GR. Male hypogonadism: management strategies. News and views on male testosterone deficiency. 4 Supplement to Renal &Urology News 2006; 1 (3).
62. Cunningham GR. Testosterone replacement therapy for late-onset hypogonadism. Nat Clin Pract Urol 2006; 3(5):260-267.
63. Davis SR, Moreau M, Kroll R, Bouchard c, Panay N, Gass M, Braunstein GD, Hirschberg AL, Rodenberg c, Pack s, Koch H, Moufarege A, Studd J. Testosterone for low libido in postmenopausal women not taking estrogen. N Engl J Med 2008; 359 (19): 2005-17.

64. De Rosa M, Paesano L, Nuzzo V, et al. Bone mineral density and bone markers in hypogonadotropic and hypergonadotropic hypogonadal men after prolonged testosterone treatment. J Endocrinol Invest 2001; 24(4):246-252.
65. Derby CA, Zilber s, Brambilla D, Morales KH, McKinlay JB. Body mass index, waist circumference and waist to hip ratio and change in sex steroid hormones: the Massachusetts Male Ageing Study. Clin Endocrinol (Oxf) 2006; 65:125-131.
66. Deslypere JP, Vermeulen A. Leydig cell function in normal men: the effectof age, life-style, residence, diet, and activity. J Clin Endocrinol Metab 1984; 59:955-962
67. Dindyal s. The sperm count has been decreasing steadily for many years in Western industrialised countries: Is there an endocrine basis for this decrease?. The Internet Journal of Urology 2007; 2 (1): 1-21.
68. Ding EL, Song Y, Malik vs, Liu s. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta¬analysis. JAMA 2006; 295:1288-1299.
69. Diver MJ, Imtiaz KE, Ahmad AM, et al. Diurnal rhythms of serum total, free and bioavailable testosterone and of SHBG in middle- aged men compared with those in young men. Clin Endocrinol (oxf) 2003;58:710-17.
70. Ehrenreich H, Halaris A, Ruether E, et al. Psychoendocrine sequelae of chronic testosterone deficiency. J Psychiatr Res 1999; 33b:379-387.
71. Emmelot-Vonk MH, Verhaar HJ, Nakhai Pour HR, Aleman A, LockTM, Bosch JL, Grobbee DE, van der Schouw YT. Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial. JAMA 2008; 299(1): 39-52.
72. Emmelot-Vonk MH, Verhaar HJ, Nakhai Pour HR. Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial. JAMA 2008; 299(6):634.


Vai trò của Testosterone trong bệnh tim mạch chuyển hóa
73. Engel JB, Schally AV. Drug Insight: clinical use of agonists and antagonists of luteinizing-hormone-releasing hormone. Not Clin PractEndocrinol Metab 2007; 3 (2): 157-67.
74. English KM, Steeds RP, Jones TH, Diver MJ, Channer KS. Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: a randomized, double-blind, placebo- controlled study. Circulation 2000; 102:1906-1911.
75. Epperson c, Haga K, Mason G, Sellers E, Gueorguieva R, Zhang w, et al. Cortical y-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder. Arch Gen Psychiatry 2002; 59:851-858.
76. Exton MS, Bindert A, Kruger T, Scheller F, Hartmann u, Schedlowski M. Cardiovascular and endocrine alterations after masturbation- induced orgasm in women. Psychosom Med 1999; 61 (3): 280-9.
77. Feldman HA, Goldstein I, Hatzichristou DG, et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994; 151:54-61.
78. Feldman HA, Longcope c, Derby CA, et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts Male Aging Study. J Clin Endocrinol Metab 2002; 87:589-598.
79. Ferrando AA, Sheffield-Moore M, Paddon-Jones D, Wolfe RR, Urban RJ. Differential anabolic effects of testosterone and amino acid feeding in older men. J Clin Endocrinol Metab 2003; 88:358-362.
80. Fink HA, Ewing SK, Ensrud KE, et al. Association of testosterone and estradiol deficiency with osteoporosis and rapid bone loss in older men. J Clin Endocrinol Metab 2006; 91 (10):3908-39015.
81. Fonda SJ, Bertrand R, O'Donnell A, Longcope c, McKinlay JB. Age, hormones, and cognitive functioning among middle aged and elderly memcross-sectionalevidencefromtheMassachusettsMaleAgingStudy. J Gerontol A Biol Sci Med Sci 2005; 60:385-390.

82. Fox CA, Ismail AA, Love DN, Kirkham KE, Loraine JA. Studies on the relationship between plasma testosterone levels and human sexual activity. J Endocrinol 1972; 52 (1): 51-8.
83. Fuller SJ,Tan RS, Martins RN. Androgens in the etiology of Alzheimer's disease in aging men and possible therapeutic interventions. J. Alzheimers Dis 2007; 12 (2): 129-42.
84. Giagulli VA, Kaufman JM, Vermeulen A. Pathogenesis of the decreased androgen levels in obese men. J Clin Endocrinol Metab 1994; 79:997- 1000.
85. Gibbs RB, Gabor R. Estrogen and cognition: applying preclinical findings to clinical perspectives. JNeurosci Res 2003; 74(5):637-643.
86. Goldey KL, van Anders SM. Sexy thoughts: effects of sexual cognitions on testosterone, cortisol, and arousal in women. Horm 8eW 2011; 59 (5): 754-64.
87. Gonacharov N, Katsya G, Dobracheva A, Nizhnik A, Kolesnikova G, Herbst V, Westermann J. Diagnostic significance of free salivary testosterone measurement using a direct luminescence immunoassay in healthy men and in patients with disorders of androgenic status. Aging Male 2006; 9:111 -122.
88. Gooren LJ.Endocrineaspectsofageing inthemale. Mol Cell Endocrinol 1998; 145:153-159.
89. Gould DC, Petty R. The male menopause: does it exist?: For: Some men need investigation and testosterone treatment. 14/esf J Med 2000; 173 (2): 76-8.
90. Grant p. Spearmint herbal tea has significant anti-androgen effects in polycystic ovarian syndrome. A randomized controlled trial. Phytother Res 2010; 24 (2): 186-8.
91. Gray A,Feldman HA,McKinlayJB,LongcopeC. Age,disease,andchanging sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study. J Clin Endocrinol Metab 1991; 73:1016-1025.

92. Gray PB, Singh AB, Woodhouse LJ, et al. Dose-dependent effects of testosterone on sexual function, mood, and visuospatial cognition in older men. J Clin Endocrinol Metab 2005; 90:3838-3846.
93. Greco EA, Spera G, Aversa A. Combining testosterone and PDE5 inhibitors in erectile dysfunction: basic rationale and clinical evidences. Eur Urol 2006; 50:940-947.
94. Gruenewald DA, Matsumoto AM. Testosterone supplementation therapy for older men: potential benefits and risks. J Am Geriatr Soc 2003;51:101-115.
95. Guay AT, Spark RF,BansalS, Cunningham GR, Goodman NF, Nankin HR, Petak SM, Perez JB. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of male sexual dysfunction: a couple's problem-2003 update. Endocr Pract 2003; 9(1): 77-95.
96. Haddad RM, Kennedy cc, Caples SM, Tracz MJ, Boloha ER, Sideras K, Uraga MV, Erwin PJ, Montori VM. Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebo-controlled trials. Mayo Clin Proc 2007; 82 (1): 29-39.
97. Haddad RM, Kennedy cc, Caples SM.Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebo-controlled trials. Mayo Clin Proc 2007; 82(1 ):11 -13.
98. Hak AE, Witteman JCM, de Jong FH, Geerlings Ml, Hofman A, Pols HAP. Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam study. J Clin Endocrinol Metab 2002; 87:3632-3639.
99. Hằkonsen LB, Thulstrup AM, Aggerholm AS, Olsen J, Bonde JP, Andersen CY, Bungum M, Ernst EH, Hansen ML, Ernst EH, Ramlau- Hansen CH. Does weight loss improve semen quality and reproductive hormones? Results from a cohort of severely obese men. Reprod Health 2011; 8: 24.
100. Harding SM, Velotta JP. Comparing the relative amount of

testosterone required to restore sexual arousal, motivation, and performance in male rats. Horm Behav 2011; 59 (5): 666-73.
101. Harman SM, Blackman MR. The effects of growth hormone and sex steroid on lean body mass, fat mass, muscle strength, cardiovascular endurance and adverse events in healthy elderly women and men. Harm Res 2003;60:121-124.
102. Heinemann LA, Saad F, Heinemann K, Thai DM. Can results of the Aging Males' Symptoms (AMS) scale predictthose of screening scales for androgen deficiency. Aging Male 2004; 7:211-218.
103. Hiipakka RA, Liao s. Molecular mechanism of androgen action. Trends Endocrinol Metab 1998; 9 (8): 317-24.
104. Hogervorst E, Bandelow s, Combrinck M, Smith AD. Low free testosterone is an independent risk factor for Alzheimer's disease. Exp Gerontol 2004; 39:1633-1639.
105. Holzbeierlein JM, Castle E, Thrasher JB. Complications of androgen deprivation therapy: prevention and treatment. Oncology (Williston Park) 2004; 18(3)303-309.
106. Howell SJ, Radford JA, Adams JE, et al. Randomized placebo- controlled trial of testosterone replacemnt in men with mild Leydig cell insufficiency following cytotoxic chemotherapy. Clin Endocrinol (Oxf; 2001; 55:315-324.
107. Hulmi JJ, Ahtiainen JPZ Selanne H, Volek JS, Hãkkinen K, Kovanen V, Mero AA. Androgen receptors and testosterone in men-effects of protein ingestion, resistance exercise and fiber type. J Steroid Biochem Mol Biol 2008; 110 (1-2): 130-7.
108. Isidori AM, Giannetta E, Gianfrilli D, et al. Effects of testosterone on sexual function in men: results of a meta-analysis. Clin Endocrinol 2005;63:601-602.
109. Jain p, Rademaker AW, McVary KT. Testosterone supplementation for erectile dysfunction: results of a meta-analysis. J Urol 2000; 164:371-375.


Vai trò của Testosterone trong bệnh tim mạch chuyển hóa
110. James PJ, Nyby JG, Saviolakis GA. Sexually stimulated testosterone release in male mice (Mus musculus): roles of genotype and sexual arousal. Harm Behav 2006; 50 (3): 424-31.
111. Jockenhovel F, Vogel E, Kreutzer M, Reinhardt w, Lederbogen s, Reinwein D. Pharmacokinetics and pharmacodynamics of subcutaneous testosterone implants in hypogonadal men. Clin Endocrinol 1996;45:61-71.
112. Johnson MW, Anch AM, Remmers JE. Induction of the obstructive sleep apnea syndrome in a woman by exogenous androgen administration. Am Rev RespirDis 1984; 129:1023-1025.
113. Jones TH, Saad F. The effects of testosterone on risk factors for, and the mediators of, the atherosclerotic process. Atherosclerosis 2009; 207 (2): 318-27.
114. Jones TH. Testosterone associations with erectile dysfunction, diabetes and the metabolic syndrome. EurUrol (Suppl) 2007; 6:847-857.
115. Josephs RA, Guinn JS, Harper ML, Askari F. Liquorice consumption and salivary testosterone concentrations. Lancet 2001; 358 (9293): 1613-4.
116. Kalme T, Seppala M, Qiao Q, et al. Sex hormone-binding globulin and insulin-like growth factor-binding protein-1 as indicators of metabolic syndrome, cardiovascular risk, and mortality in elderly men. J Clin Endocrinol Metab 2005; 90:1550-1556.
117. Kalyani RR, Gavini s, Dobs AS. Male hypogonadism in systemic disease. Endocrinol Metab Clin North Am 2007; 36(6):333-348.
118. Kanayama G, Amiaz R, Seidman SN, Pope HGJ. Testosterone supplementation for depressed men: current research and suggested treatment guidelines. Exp Clin Psychopharmacol 2007; 15:529-538.
119. Kapoor D, Clarke s, Channer KS, et al. Erectile dysfunction is associated with low bioactive testosterone levels and visceral adiposity in men with type 2 diabetes. IntJAndrol 2007; 30:500-7.

120. Kapoor D, Goodwin E, Channer KS, Jones TH. Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. EurJ Endocrinol 2006; 154:899-906.
121. Karazindiyanoglu s, Cayan s. The effect of testosterone therapy on lower urinary tractsymptoms/bladder and sexual functions in men with symptomatic late-onset hypogonadism. Aging Male 2008; 11(3):146-149.
122. Kaukua J, Pekkarinen T, SaneT, Mustajoki p. Sex hormones and sexual function in obese men losing weight. Obes Res 2003; 11:689-694.
123. Kelleher s, Conway AJ, Handelsman DJ. Blood testosterone threshold for androgen deficiency symptoms. J Clin Endocrinol Metab 2004; 89:3813-3817.
124. Kenny AM, Fabregas G, Song c, Biskup B, Bellantonio s. Effects of testosterone on behavior, depression, and cognitive function in older men with mild cognitive loss. J Gerontol A Biol Sci Med Sci 2004; 59:75-78.
125. Kenny AM, Fabregas G, Song c, et al. Effects of testosterone on behavior, depression, and cognitive function in older men with mild cognitive loss. J Gerontol A Biol Sci Med Sci 2004; 59:75-8.
126. Kenny AM, Prestwood KM, Gruman CA, Marcello KM, Raisz LG. Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels. J Gerontol A Biol Sci Med Sei 2001; 56:266-272.
127. Khera M, Lipshultz LI. The role of testosterone replacement therapy following radical prostatectomy. Urol Clin North Am 2007; 34:549-553.
128. Kort HI, Massey JB, Elsner cw, Mitchell-Leef D, Shapiro DB, Witt MA. et al. Impactof body mass index values on sperm quantity and quality. J Androl 2006; 27:450-452.

240 MÂN DỤC NAM
Vai trò của Testosterone trong bệnh tim mạch chuyển hóa
129. Kratzik cw, Schatzl G, Lunglmaỵr G, et al. The impactof age, body mass index and testosterone on erectile dysfunction. J Urol 2005; 174:240-3.
130. Krause w, Mueller u, Mazur A. Testosterone supplementation in the aging male: which questions have been answered? Aging Male 2005;8:31-38.
131. Kupelian V, Page ST, Araujo AB, et al. Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men. J Clin Endocrinol Metab 2006; 91:843-850.
132. Laaksonen DE, Niskanen L, Punnonen K, et al.Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care 2004; 27:1036-41.
133. Laughlin GA, Barrett-Connor E, Bergstrom J. Low serum testosterone and mortality in older men. J Clin Endocrinol Metab 2008; 93:68-75.
134. Lee CH, Kuo sw, Hung YJ, et al. The effectof testosterone supplement on insulin sensitivity, glucose effectiveness, and acute insulin response after glucose load in male type 2 diabetics. Endocr Res 2005;31:139-48.
135. Lewis R, KapurS, Jone c, DaSilva J, Brown G, Wilson A, et al. Serotonin 5-HT2 receptors in schizophrenia: a PET study using [18F]setoperone in neuroleptic-naive patients and normal subjects. Am J Psychiatry 1999; 156:72-78.
136. Liu PY, Pincus SM, Takahashi PY, Roebuck PD, Iranmanesh A, Keenan DM, Veldhuis JD. Aging attenuates both the regularity and joint synchrony of LH and testosterone secretion in normal men: analyses via a model of graded GnRH receptor blockade. Am J Physiol Endocrinol Metab 2006; 290 (1): E34-E41.
137. Lu PH, Masterman DA, Mulnard R, Cotman c, Miller B, Yaffe K, et al. Effects of testosterone on cognition and mood in male patients

with mild Alzheimer disease and healthy elderly men. Arch Neurol 2006;63:177-185.
138. Luboshitzky R, Aviv A, Hefetz A, et al. Decreased pituitary-gonadal secretion in men with obstructive sleep apnea. J Clin Endocrinol Metab 2002; 87:3394-8.
139. Lunenfeld B, Nieschlag E. Testosterone therapy in the aging male. Aging Male 2007; 10:139-153.
140. Lyngdorf p, Hemmingsen L. Epidemiology of erectile dysfunction and its risk factors: a practice-based study in Denmark. IntJ Impot Res 2004;16:105-111.
141. Ma RC-W, So W-Y, Yang X, Yu LW-L, Kong AP-S, Ko GT-C, et al. Erectile dysfunction predicts coronary heart disease in type 2 diabetes. J Am Coll Cardiol 2008; 51:2045-2050.
142. Maggio M, Basaria s, Ble A, et al. Correlation between testosterone and the inflammatory marker soluble interleukin-6 receptor in older men. J Clin Endocrinol Metab 2006; 91:345-7.
143. Mahmoud A, Comhaire FH. Mechanisms of disease: late-onset hypogonadism. Nat Clin Pract Urol 2006; 3 (8): 430-8.
144. Maki PM, Ernst M, London ED, Mordecai KL, Perschler p, Durso SC, et al. Intramuscular testosterone treatment in elderly men: evidence of memory decline and altered brain function. J Clin Endocrinol Metab 2007; 92:4107-4114.
145. Makinen J, Jarvisalo MJ, Pollanen p, Perheentupa A, Irjala K, Koskenvuo M, et al. Increased carotid atherosclerosis in andropausal middle-aged men. J Am Coll Cardiol 2005; 45:1603-1608.
146. Marazziti D, Canale D. Hormonal changes when falling in love. Psychoneuroendocrinology 2004; 29 (7): 931-6.
147. Marin DP, Figueira AJ Junior, Pinto LG. One session of resistance training may increase serum testosterone and triiodetironine in young men. Medicine & Science in Sports & Exercise 2006; 38 (5): S285.


Vai trò của Testosterone trong bệnh tim mạch chuyển hóa
148. Marner L, Nỵengaard JR, Tang Y, Pakkenberg B. Marked loss of myelinated nerve fibers in the human brain with age. J Comp Neurol 2003; 462 (2): 144-52.
149. Martin DM,WittertG, Burns NR, Haren MT, Sugarman R.Testosterone and cognitive function in ageing men: data from the Florey Adelaide Male Ageing Study (FAMAS). Maturitas 2007; 57:182-194.
150. Matsumoto AM. Andropause: Clinical implications of the decline in serum testosterone levels with aging in men. J Gerontol Med Sci 2002; 57:76-99.
151. Mazur A, Michalek J. Marriage, Divorce, and Male Testosterone. Social Forces 1998; 77 (1): 315-330.
152. McNicholas TA, Dean JD, Mulder H, Carnegie c, Jones NA. A novel testosterone gel formulation normalizes androgen levels in hypogonadal men, with improvements in body composition and sexual function. BJUInt 2003; 91:69-74.
153. Mehta PH, Josephs RA. Testosterone change after losing predicts the decision to compete again. Horm Behav 2006; 50 (5): 684-92.
154. Meier c, Nguyen TV, Handelsman DJ, et al. Endogenous sex hormones and incident fract urê risk in older men: the Dubbo Osteoporosis Epidemiology Study. Arch Intern Med 2008; 168:47-54.
155. Michael H, Harkonen PL, Vããnãnen HK, Hentunen TA. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption. J Bone Miner Res 2005; 20(12):2224-2232.
156. Miner M, Canty DJ, Shabsigh R. Testosterone replacement therapy. Postgrad Med 2008; 120(3): 130-153.
157. Moffat SD, Zonderman AB, Metter EJ, Kawas c, Blackman MR, Harman SM, Resnick SM. Free testosterone and risk for Alzheimer disease in older men. Neurology 2004; 62 (2): 188-93.

158. Mooradian AD, Korenman SG. Management of the cardinal features of andropause. Am J Ther 2006; 13 (2): 145-60.
159. Moore c, Huebier D, Zimmermann T, Heinemann LA, Saad F, Thai DM. The Aging Males'Symptoms scale (AMS) as outcome measure for treatment of androgen deficiency. Eur Urol 2004; 46:80-87.
160. Morales A, Schulman CC,Tostain J, Wu FCW.Testosterone deficiency syndrome (TDS) needs to be named appropriately-the importance of accurate terminology. Eur Urol 2006; 50:407-409.
161. Morales A, Spevack M, Emerson L, et al. Adding to the controversy: pitfalls in the diagnosis of testosterone deficiency syndromes with questionnaires and biochemistry. Aging Male 2007; 10:57-65.
162. Morgentaler A, Schulman c.Testosterone and prostate safety. Front Horm Res. Frontiers of Hormone Research 2009; 37:197-203.
163. Morgentaler, A. and A.M. Traish. Shifting the paradigm of testosterone and prostate cancer: the saturation model and the limits of androgen-dependent growth. Ear Urol 2009; 55 (2): 310-20.
164. Morley JE, Perry HM, III, Kevorkian RT, Patrick p. Comparison of screening questionnaires for the diagnosis of hypogonadism. Maturitas 2006; 53:424-429.
165. Morley JE, Perry HM, III, Patrick p, Dollbaum CM, Kells JM. Validation of salivary testosterone as a screening test for male hypogonadism. Aging Male 2006; 9:165-169.
166. Morley JE. Testosterone replacement in older men and women. J Gend Specif Med 2001; 4:49-53.
167. Muller M, van den Beld AW, Bots ML, Grobbee DE, Lamberts sw, vander Schouw YT. Endogenous sex hormones and progression of carotid atherosclerosis in elderly men. Circulation 2004; 109:2074-2079.
168. Myers JB, Meacham RB. Androgen Replacement Therapy in the Aging Male Rev ưro/ 2003; 5 (4): 216-26.


Vai trò của Testosterone trong bệnh tim mạch chuyển hóa
169. Nettleship JE, Jones TH, Channer KS, Jones RD. Physiological testosterone replacement therapy attenuates fatty streak formation and improves high-density lipoprotein cholesterol in the Tfm mouse. Circulation 2007; 116:2427-2434.
170. Nieschlag E, Behre HM, Bouchard p, et al.Testosterone replacement therapy: current trends and future directions. Hum Reprod Update 2004; 10:409-19.
171. Nieschlag E, Swerdloff R, Behre HM, et al. Investigation, treatment and monitoring of late-onset hypogonadism in males. Aging Male 2005; 8:56-58.
172. Orwoll E, Lambert LC, Marshall LM, et al. Testosterone and estradiol in older men. J Clin Endocrinol Metab 2006; 91:1336-1344.
173. Page ST, Amory JK, Bowman FD, et al. Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T. J Clin Endocrinol Metab 2005; 90:1502-1510.
174. Perry PJ, Yates WR, Williams RD, et al. Testosterone therapy in late- life major depression in males. J Clin Psychiatry 2002; 63:1096-1101.
175. Phillips GB, Jing T, Heymsfield SB. Relationships in men of sex hormones, insulin, adiposity, and risk factors for myocardial infarction. Metabolism 2003; 52:784-90.
176. Pike CJ, Rosario ER, Nguyen TV. Androgens, aging, and Alzheimer's disease. Endocrine 2006; 29 (2): 233-41.
177. Pilz s, Frisch s, Koertke H, Kuhn J, Dreier J, Obermayer-Pietsch B, Wehr E, Zittermann A. Effect of vitamin D supplementation on testosterone levels in men. Horm Metab Res 2011; 43 (3): 223-5.
178. Pitteloud N, Mootha VK, Dwyer AA, et al. Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men. Diabetes Care 2005; 28:1636-1642.

179. Pugh PJ, Jones RD, West JN, et al. Testosterone treatment for men with chronic heart failure. Heart 2004; 90:446-7.
180. Pugh PJ, Jones TH, Channer KS. Acute haemodynamic effects of testosterone in men with chronic heart failure. Eur Heart J 2003; 24:909-15.
181. Ramlau-Hansen CH, Hansen M, Jensen CR, Olsen J, Bonde JP, Thulstrup AM. Semen quality and reproductive hormones according to birthweight and body mass index in childhood and adult life: two decades of follow-up. Fertil Steril 2010; 94:610-618.
182. Reed WL, Clark ME, Parker PG, Raouf SA, Arguedas N, Monk DS, Snajdr E, Nolan V, Ketterson ED. Physiological effects on demography: a long-term experimental study of testosterone's effects on fitness. Am Nat 2006; 167 (5): 667-83.
183. Rhoden EL, Averbeck MA, Teloken PE. Androgen replacement in men undergoing treatment for prostate cancer. J Sex Med 2008; 5(9):2202-2208.
184. Rhoden EL, Ribeiro EP,Teloken c, et al. Diabetes mellitus is associated with subnormal serum levels of free testosterone in men. BJU Int 2005; 96:867-70.
185. Riccardi p, Zald D, Li R, Park s, Ansari MS, Dawant B, et al. Sex differences in amphetamine-induced displacement of t(18)F] fallypride in striatal and extrastriatal regions: a PET study. Am J Psychiatry 2006; 163:1639-41.
186. Rochira V, Balestrieri A, Faustini-Fustini M, Carani c. Role of estrogen on bone in the human male: insights from the natural models of congenital estrogen deficiency. Mol Cell Endocrinol 2001; 178:215-220.
187. Roddam AW, Allen NE, Appleby p, KeyTJ. Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies. J Natl Cancer Inst 2008; 100:170-83.


Vai trò của Testosterone trong bệnh tim mạch chuyển hóa
188. Rodríguez A, Muller DC, Metter EJ, et al. Aging, androgens, and the metabolic syndrome in a longitudinal study of aging. J Clin Endocrinol Metab 2007; 92:3568-3572.
189. Rosario ER, Chang L, Stanczyk FZ, Pike CJ. Age-related testosterone depletion and the development of Alzheimer disease. JAMA 2004; 292 (12): 1431-2.
190. Rosner w, Auchus RJ, Azziz R, Sluss PM, Raff H. Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab 2007; 92:405-13.
191. Ross RJ, Jabbar A, Jones TH, et al. Pharmacokinetics and tolerability of a bioadhesive buccal testosterone tablet in hypogonadal men. EurJ Endocrinol 2004; 150:57-63.
192. Salminen EK, Portin Rl, Koskinen A, Helenius H, Nurmi M. Associations between serum testosterone fall and cognitive function in prostate cancer patients. Clin Cancer Res 2004; 10:7575-7582.
193. Sarosdy MF. Testosterone replacement for hypogonadism after treatment of early prostate cancer with brachytherapy. Cancer 2007;109:536-541.
194. Schubert M, Minnemann T, Hubler D, et al. Intramuscular testosterone undecanoate: pharmacokinetic aspects of a novel testosterone formulation during long-term treatment of men with hypogonadism. J Clin Endocrinol Metab 2004; 89:5429-34.
195. Seidman SN, Miyazaki M, Roose SP. Intramuscular testosterone supplementation to selectiveserotonin reuptake inhibitor in treatment-resistant depressed men: randomized placebo- controlled clinical trial. J Clin Psychopharmacol 2005; 25:584-588.
196. Seidman SN, Spatz E, Rizzo c, Roose SP. Testosterone replacement therapy for hypogonadal men with major depressive disorder: a randomized, placebo-controlled clinical trial. J Clin Psychiatry 2001; 62(6):406-412.

197. Selvin E, Burnett AL, Platz EA. Prevalence and risk factors for erectile dysfunction in the US. Am J Med 2007; 120:151-157.
198. Selvin E, Feinleib M, Zhang L, et al. Androgens and diabetes in men: results from the Third National Health and Nutrition Examination Survey (NHANES III). Diabetes Care 2007; 30:234-238.
199. Shabsigh R, Kaufman JM, Steidle c, Padma-Nathan H. Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone. J Urol 2004; 172:658-663.
200. Shabsigh R. Testosterone therapy in erectile dysfunction and hypogonadism. J Sex Med 2005; 2:785-92.
201. ShamlianNT,ColeMG.Androgentreatmentofdepressivesymptoms in older men: a systematic review of feasibility and effectiveness. Can J Psychiatry 2006; 51:295-299.
202. Shores MM, Matsumoto AM, Sloan KL, Kivlahan DR. Low serum testosterone and mortality in male veterans. Arch Intern Med 2006; 166:1660-1665.
203. Smith AM, English KM, Malkin CJ, et al. Testosterone does not adversely affectfibrinogen or tissue plasminogen activator (tPA) and plasminogen activator inhibitor-1 (PAI-1) levels in 46 men with chronic stable angina. EurJ Endocrinol 2005; 152:285-91.
204. Staley J, Sanacora G,Tamagnan G, Maclejewski p, Malison RT, Berman RM, et al. Sex differences in diencephalon serotonin transporter availability in major depression. Biol Psychiatry 2005; 59:40-47.
205. stanworth RD, Jones TH. Testosterone for the aging male; current evidence and recommended practice. Clin Interv Aging 2008; 3 (1): 25-44.
206. stattin p, Lumme s, Tenkanen L, et al. High levels of circulating testosterone are not associated with increased prostate cancer risk: a pooled prospective study. Int J Cancer 2004; 108:418-24.


Vai trò của Testosterone trong bệnh tim mạch chuyển hóa
207. Svartberg J, Agledahl I, Figenschau Y, SildnesT, Waterloo K, Jorde R. Testosterone treatment in elderly men with subnormal testosterone levels improves body composition and BMD in the hip. IntJ Impot Res 2008; 20(4)378-387
208. Swaab DF, Garcia-Falgueras A. Sexual differentiation of the human brain in relation to gender identity and sexual orientation. Funct Neuro/2009; 24(1): 17-28.
209. Swerdloff RS, Wang c. Three-year follow-up of androgen treatment in hypogonadal men: preliminary report with testosterone gel. Aging Male 2003; 6:207-211.
210. Tan RS, Culberson JW. An integrative review on current evidence of testosterone replacement therapy for the andropause. Maturitas 2003;45:15-27.
211. Thompson IM, Carroll PR, Carducci MA. Recommendations for defining and treating high risk localized prostate cancer. J Urol 2006; 17636-S10.
212. Tivesten A, Mellstrom D, Jutberger H, Fagerberg B, Lernfelt B, Orwoll E, et al. Low serum testosterone and high serum estradiol associate with lower extremity peripheral arterial disease in elderly men. The MrOS Study in Sweden. J Am Coll Cardiol 2007; 50:1070-1076.
213. Torjesen PA, Sandnes L. Serum testosterone in women as measured by an automated immunoassay and a RIA. Clin Chem 2004. 50 (3): 678.
214. Traish AM, Kim N, Min K, Munarriz R, Goldstein I. Role of androgens in female genital sexual arousal: receptor expression, structure, and function. Fertil Steril 2001; 77 Suppl 4: S11-8.
215. Traish AM, Saad F, Guay A. The dark side of testosterone deficiency: II.Type 2 diabetes and insulin resistance.JAndrol 2009; 30(1): 23-32.
216. Travison TG, Morley JE, Araujo AB, O'Donnell AB, McKinlay JB. The relationship between libido and testosterone levels in aging men. J Clin Endocrinol Metab 2006; 91:2509-2513.

217. Luiten A, Van Honk J, Koppeschaar H, Bernaards c, Thijssen J, Verbaten R.Time course of effects of testosterone administration on sexual arousal in women. Arch Gen Psychiatry 2000; 57 (2): 149-53.
218. Urban RJ, Bodenburg c, Gilkison c, et al.Testosterone administration to elderly men increases skeletal muscle strength and protein synthesis. Am J Physiol 1995; 269:E820-E826.
219. Van Anders SM, Dunn EJ. Are gonadal steroids linked with orgasm perceptions and sexual assertiveness in women and men?. Horm BeW 2009; 56 (2): 206-13.
220. Van Anders SM, Hamilton LD, Schmidt N, Watson NV. Associations between testosterone secretion and sexual activity in women. Worm Behứv 2007; 51 (4): 477-82.
221. Van den Beld AW, Bots ML, Janssen JA, Pols HA, Lamberts sw, Grobbee DE. Endogenous hormones and carotid atherosclerosis in elderly men. Am J Epidemiol 2003; 157:25-31.
222. Van den Beld AW, de Jong FH, Grobbee DE, Pols HA, Lamberts sw. Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men. J Clin Endocrinol Metab 2000; 85:3276-3282.
223. Vermeulen A. Hormonal cut-offs of partial androgen deficiency: a survey of hormon sinh dục nam assays. J Endocrinol Invest 2005; 28:28-31.
224. WallenK.Sexandcontext:hormonesandprimatesexualmotivation. Horm Behav 2001; 40 (2): 339-57.
225. Wang c, Nieschlag E, Swerdloff R, et al. Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations. Ear J Endocrinol 2008; 159:507-514.
226. Wang c, Swerdloff R, Kipnes M, Matsumoto AM. New testosterone buccal system (Striant) delivers physiological testosterone levels:


Vai trò của Testosterone trong bệnh tim mạch chuyển hóa
pharmacokinetics study in hỵpogonadal men. J Clin Endocrinol Metab 2004; 89:3821-3829.
227. Webb CM, Adamson DL, de Zeigler D, et al. Effect of acute testosterone on myocardial ischemia in men with coronary artery disease. Am J Cardiol 1999; 83:437-9. A9.
228. Weiss JM, Huang WY, Rinaldi s. Endogenous sex hormones and the risk of prostate cancer: a prospective study. Int J Cancer 2008; 122(10):2345-2350.
229. Wilson JD. Androgens, androgen receptors, and male gender role behavior. Horm Behav 2001; 40 (2): 358-66.
230. Yaffe K, Lui LY, Zmuda J, et al. Sex hormones and cognitive function in older men. J Am GeriatrSoc 2002; 50:707-12.
231. Yeap BB, Almeida OP, Hyde z, Chubb SAP, Hankey GJ, Jamrozik K, et al. Higher serum free testosterone is associated with better cognitive function in older men, whilst total testosterone is not.The Health In Men Study. Clin Endocrinol 2008; 68:404-412.
232. Yeap BB, Almeida OP, Hyde z, et al. In men older than 70 years, total testosterone remains stable while free testosterone declines with age. The Health in Men Study. Eur J Endocrinol 2007; 156:585-594.
233. Zitzmann M, Faber s, Nieschlag E. Association of specific symptoms and metabolic risks with serum testosterone in older men. J Clin Endocrinol Metab 2006; 91:4335-4343.
234. Zitzmann M, Nieschlag E. Androgen receptor gene CAG repeat length and body mass index modulate the safety of long-term intramuscular testosterone undecanoate therapy in hypogonadal men. J Clin Endocrinol Metab 2007; 92:3844-3853.